Flerie AB Company Description

Flerie AB (publ) is a venture capital firm specializing in early-stage investments.

It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time.

The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

Flerie AB (publ)

Country	Sweden
Founded	2011
Industry	Biotechnology
Sector	Healthcare
Employees	7
CEO	Ted Fjallman

Contact Details

Address: Skeppsbron 16 Stockholm, 111 30 Sweden
Phone	46 (0)76 131 01 27
Website	flerie.com

Stock Details

Ticker Symbol	FLERIE
Exchange	Nasdaq Stockholm
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0008966295
SIC Code	2834

Key Executives

Name	Position
Cecilia Stureborg von Schéele	Chief Financial Officer and Deputy Chief Executive Officer
Dr. Ted Fjallman Ph.D.	Chief Executive Officer
Thomas Eldered M.Sc., MSc	Executive Chairman of the Board
Mark Quick	Partner
Paula Andersson	Operations and Investor Relations Manager
Karl Elmqvist	Investment Manager
Dr. Carl-Johan Spak Ph.D.	Senior Advisor
Carlos von Bonhorst M.D.	Senior Advisor
Michaela Gertz	Senior Advisor